Synthesis of heteroannulated cyclopent[b]indoles: Exploration of in vitro cytotoxicity and molecular docking studies. Issue 4 (16th February 2018)

• Record Type: Journal Article
• Authors: Satheeshkumar, Rajendran; Muthusankar, Aathi; Edatt, Lincy; Sameer Kumar, V. B.; Sparkes, Hazel A.; Rajendra Prasad, Karnam Jayarampillai
• Is Part Of: Synthetic communications. Volume 48:Issue 4(2018)
• Page Start: 447
• Page End: 461
• Publication Date: 2018-02-16
• Subjects: CK2 inhibitors -- HeLa and MCF-7 -- isoxazolo-cyclopent[b]indole -- pyrido-cyclopent[b]indole; Organic compounds -- Synthesis -- Periodicals; Chemistry, Organic; Synthesis; 547.205
• DOI: 10.1080/00397911.2017.1407792
• Languages: English
• ISSNs: 0039-7911

Abstract

ABSTRACT: A series of novel cyclopent[ b ]indole analogues that hold isoxazolo-, pyrido-templates were designed and synthesized in good yields. The in vitro cytotoxicity was concerned for all the newly synthesized compounds by MTT assay against HeLa (cervix adeno carcinoma) and MCF-7 (breast cancer). These synthesized compounds were further compared with the standard drug ellipticine, 5-fluorouracil, cisplatin, and methotrexate. The synthesized heteroannulated cyclopent[ b ]indole compounds were found to show better cytotoxic activity against HeLa and MCF-7 with primary structure activity relationship studies. To identify with the nature of interactions of these molecules, we performed molecular docking studies using the protein kinase CK2 inhibitors. The docking results afforded some valuable information for the future design of more potent inhibitors. GRAPHICAL ABSTRACT: